Department of Oncology, Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast BT9 7BL, N. Ireland, UK.
Breast Cancer Res Treat. 2010 Aug;122(3):721-31. doi: 10.1007/s10549-009-0565-0. Epub 2009 Oct 31.
Expression profiling of BRCA1-deficient tumours has identified a pattern of gene expression similar to basal-like breast tumours. In this study, we examine whether a BRCA1-dependent transcriptional mechanism may underpin the link between BRCA1 and basal-like phenotype. In methods section, the mRNA and protein were harvested from a number of BRCA1 mutant and wild-type breast cancer cell lines and from matched isogenic controls. Microarray-based expression profiling was used to identify potential BRCA1-regulated transcripts. These gene targets were then validated (by in silico analysis of tumour samples) by real-time PCR and Western blot analysis. Chromatin immunoprecipitation (ChIP) assays were used to confirm recruitment of BRCA1 to specific promoters. In results, we demonstrate that functional BRCA1 represses the expression of cytokeratins 5(KRT5) and 17(KRT17) and p-Cadherin (CDH3) in HCC1937 and T47D breast cancer cell lines at both mRNA and protein level. ChIP assays demonstrate that BRCA1 is recruited to the promoters of KRT5, KRT17 and CDH3, and re-ChIP assays confirm that BRCA1 is recruited independently to form c-Myc and Sp1 complexes on the CDH3 promoter. We show that siRNA-mediated inhibition of endogenous c-Myc (and not Sp1) results in a marked increase in CDH3 expression analogous to that observed following the inhibition of endogenous BRCA1. The data provided suggest a model whereby BRCA1 and c-Myc form a repressor complex on the promoters of specific basal genes and represent a potential mechanism to explain the observed overexpression of key basal markers in BRCA1-deficient tumours.
BRCA1 缺陷型肿瘤的表达谱分析鉴定出一种与基底样乳腺癌相似的基因表达模式。在这项研究中,我们研究了 BRCA1 依赖性转录机制是否可能是 BRCA1 与基底样表型之间联系的基础。在方法部分,从许多 BRCA1 突变和野生型乳腺癌细胞系以及匹配的同基因对照中提取了 mRNA 和蛋白质。基于微阵列的表达谱分析用于鉴定潜在的 BRCA1 调节转录物。然后通过实时 PCR 和 Western blot 分析对这些基因靶标进行了验证(通过对肿瘤样本的计算机分析)。染色质免疫沉淀(ChIP)测定用于确认 BRCA1 特异性募集到特定启动子。我们证明功能性 BRCA1 在 HCC1937 和 T47D 乳腺癌细胞系中在 mRNA 和蛋白质水平上均抑制细胞角蛋白 5(KRT5)和 17(KRT17)和 p-钙粘蛋白(CDH3)的表达。ChIP 测定表明 BRCA1 被募集到 KRT5、KRT17 和 CDH3 的启动子上,并且重新 ChIP 测定证实 BRCA1 独立募集以在 CDH3 启动子上形成 c-Myc 和 Sp1 复合物。我们表明,siRNA 介导的内源性 c-Myc(而不是 Sp1)抑制导致 CDH3 表达的显著增加,类似于观察到的内源性 BRCA1 抑制后观察到的增加。提供的数据表明了一种模型,其中 BRCA1 和 c-Myc 在特定基底基因的启动子上形成一个抑制复合物,并且代表了解释在 BRCA1 缺陷型肿瘤中观察到的关键基底标志物过度表达的潜在机制。